Last reviewed · How we verify
NCT04303455
Renin as a Biomarker of Haemodynamic Normalisation
trial testing blood sampling in Shock in 104 participants. Completed in 12 March 2021.
15 February 2021
Quick facts
| Lead sponsor | South West Sydney Local Health District |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 104 |
| Start date | 24 March 2020 |
| Primary completion | 15 February 2021 |
| Estimated completion | 12 March 2021 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- blood sampling — full drug profile →
Conditions studied
- Shock — all drugs for Shock →
Sponsor
South West Sydney Local Health District — full company profile →
Who can join
18 and older, any sex, with Shock. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study design Observational, single centre, prospective cohort study Planned sample size 100 participants Inclusion criteria The study will evaluate a cohort of participants meeting the following inclusion criteria: 1. admission to the Intensive Care Unit (ICU) after elective and emergency cardiac surgery using cardiopulmonary bypass 2. age 18 years and above 3. arterial, central venous and pulmonary arterial catheters have been inserted as part of routine care Study procedures In addition to routine clinical postoperative data and blood collection, serum renin levels will be analysed on admission, 6 and 24 hours after admission to ICU Study duration 6 months
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04303455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of blood sampling
Trials testing the same drug.
- NCT07467109 — A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of · not yet recruiting
- NCT07347613 — Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study · not yet recruiting
- NCT07472387 — Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas · NA · not yet recruiting
- NCT07477769 — Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · not yet recruiting
- NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting
Other recruiting trials for Shock
Currently open trials in the same condition.
- NCT07273643 — Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With · recruiting
- NCT07009665 — Fluid Management and Individualized Resuscitation in Sepsis · NA · recruiting
- NCT06713668 — Augmented Pacing for Shock in the Cardiac Intensive Care Unit · NA · recruiting
- NCT06930235 — Effectiveness of Midodrine as an Adjuvant to Norepinephrine in Weaning Critically Ill Patients From Vasopressors · NA · recruiting
- NCT06920173 — Pulse Study: Peripheral Use of Low-dose Vasopressors for Safety and Efficacy in the Intensive Care Unit · Phase 2 · recruiting
Other South West Sydney Local Health District trials
Trials by the same sponsor.
- NCT07292519 — Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/ · Phase 2 · not yet recruiting
- NCT07247370 — Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL) · Phase 1, PHASE2 · not yet recruiting
- NCT06980129 — Rehabilitation in the Home After Hip Fracture · NA · not yet recruiting
- NCT05540834 — Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure · Phase 2 · recruiting
- NCT05082168 — Capnodynamic Monitoring of Cardiorespiratory Function in Critically Ill Patients · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04303455 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South West Sydney Local Health District
- Last refreshed: 24 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04303455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing